AdvaMed

Study after study highlights the critical role of artificial intelligence in helping doctors diagnose disease. The latest study finds an AI-enabled analysis of MRI scans correctly differentiated Parkinson’s disease from related disorders 96 percent of the time. This is important because diagnostic precision improves clinical care, and Parkinson’s disease can be hard to diagnose, especially in the early stages. A recent study in The Lancet shows a 29 percent increase in cancer detection when AI is used to support screening without increasing false positives. The findings also show the AI-supported screening clearly detected more invasive cancers at an early stage. It’s exciting to consider how many more ways AI applications will transform patient care. https://lnkd.in/gZE-T279

It was great to have our Board chair, GE HealthCare's Peter J Arduini, and Board members Geoff Martha of Medtronic and Boston Scientific's Mike Mahoney lead a number of critical conversations around the Hill and with Administration officials last week on the issues facing our?industry. Their voices, their unique perspectives as business leaders, the stories of their companies’ lifesaving medical technologies, their respective success stories as U.S. manufacturers … all of it adds crucial color to the policies and legislative proposals necessary to ensure the no. 1 #medtech?industry?in?the world can continue to meet patients’ needs and maintain?its global leadership role. We spoke with health care leaders?in?the Senate, with leadership at the U.S. Trade Representative and CMS, and with White House officials on a range of topics. The conversations were positive, and our message was clear: We must be careful with tariffs and the impact they could have on the health care supply chain?as well as U.S. manufacturing,?innovation and jobs, not to mention the possibility that they may actually put other global players at a comparative advantage over the U.S. medtech?industry. We also shared with CMS two of our top priorities. The first is to significantly expand the Biden administration’s Transitional Coverage of Emerging Technologies (TCET) policy to look a lot more like the Medicare Coverage of Innovative Technologies (MCIT) policy implemented by the first Trump administration. Our view is simple: There really is no need for Medicare to stand?in?the way of its beneficiaries’ access to FDA-approved “breakthrough” medical technologies if their doctors believe those technologies could help alleviate their suffering. We feel good about the bipartisan support in Congress for this policy that will both transform patients’ lives and make our government more effective and efficient. Our second priority at CMS is that the agency struggles to keep pace with our?industry and even the FDA that regulates it—and that really needs to change … dramatically. It is time to streamline and improve the CMS decision-making process so that it is at least as efficient, transparent, and predictable as the FDA review process. Medicare and Medicaid patients deserve as much. Thank you to the officials and staff who met with us, and thank you, Pete, Geoff, and Mike, for prioritizing these meetings and making this?happen. Your leadership is critical to our advocacy on our industry's behalf?in?Washington and around the world.

Congratulations to our 2025 class of Leading Association Lobbyists: Greg Crist of AdvaMed, Jennifer Fox of Finseca, Carl Holshouser of TechNet: The Voice of the Innovation Economy, and Jason G. Ortega, JD, MBA, CAE of National Wooden Pallet & Container Association (NWPCA)! #Salute2025 #associations #assnchat #S2E25 Photo credit: Leigh Vogel

The landscape of inbound trade and investment is evolving, with shifting tariff policies and regulatory challenges impacting medtech companies. In-house counsel must be prepared to navigate these complexities and mitigate risks.?? ?? Join Medtech's best legal minds for a deep dive on trade and tariff law: Inbound?Trade & Investment: Strategies for Medtech in the Era of Tariffs & Trade Legal and Policy Shifts,?a CLE-accredited webinar presented by legal experts at Akin Gump. This session will provide critical insights into the latest trade policies, compliance risks, and strategic approaches for medtech companies.?? ? This webinar is free for AdvaMed Members, $149 for Non-Members?? ? #medtech #tariffs #globaltrade #CLEwebinar? Link: https://lnkd.in/eima5XRV?

Congratulations to Greg and the AdvaMed federal government affairs team for being recognized as a 2024 Leading Lobbyist by Association TRENDS & CEO Update.?This is an important award in the association business and a clear recognition of the power of results in advocacy. Greg and the team at AdvaMed, along with our #medtech member companies, have always stayed focused on our mission to shape a public policy environment that values innovation and accelerates access to the medical technologies that will improve the life of every patient, every time.?Congratulations, Greg and team – Kim Zimmerman Bobby Patrick, VI Sarah Killeen Amanda Walsh Nicholas Halsted Susan Askew Julia Torregrosa Roxy Kozyckyj Darbi Gottlieb Peter Weems Adrienne F. Rachel Kosh, MPH Alexandra Miller, MPH

?? Celebrating Women Driving Innovation in MedTech ?? Tomorrow is #Internationalwomensday, and we want to recognize the incredible contributions of #womeninmedtech—from pioneering groundbreaking medical technologies to shaping policy, leadership, and patient care. AdvaMed Women’s Executive Network (WEN) brings together industry leaders, rising executives, and changemakers to support, mentor, and empower women in medtech. At #MTC24 we heard from the WEN through panel discussions focused on shattering the glass ceiling and empowering other female leaders and got together for the WEN reception for collaboration, connection, and career growth. This International Women’s Day, we celebrate the progress made and the work ahead to ensure more women’s voices, expertise, and leadership shape the future of healthcare. ?? Tag a woman in medtech who inspires you! We nominate Holly Scott, Lisa Earnhardt, Juliana Elstad, Nicole DeKort, Amanda DePalma, Lori Chmura, Laura Conquergood, Beth Lorden, PhD Raina Dauria, Katie Ossman, Sarah Hassaine, @janettrunzo, Paula Miller #Medtechcon #Innovation #womeninmedtech